154
|
486
|
5s9zA |
Pandda analysis group deposition -- crystal structure of trypanosoma brucei trypanothione reductase in complex with z2856434884 |
149
|
486
|
5sa1A |
Pandda analysis group deposition -- crystal structure of trypanosoma brucei trypanothione reductase in complex with z2856434944 |
78
|
237
|
7fbqA |
Human clic1 in complex with nsc602247 |
126
|
419
|
8fgdA |
Structure of rat neuronal nitric oxide synthase r349a mutant heme domain in complex with 6-(5-(2-(diethylamino)ethyl)-2,3-difluorophenethyl)-4-methylpyridin-2-amine |
122
|
418
|
8fgvA |
Structure of rat neuronal nitric oxide synthase h692f mutant heme domain in complex with 6-(5-(2-(dimethylamino)ethyl)-2,3-difluorophenethyl)-4-methoxypyridin-2-amine |
132
|
418
|
8fgaA |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 6-(5-(2-(dimethylamino)ethyl)-2,3-difluorophenethyl)-4-methylpyridin-2-amine |
127
|
418
|
8fgbA |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 4-(5-(2-(dimethylamino)ethyl)-2,3-difluorophenethyl)-6-methylpyrimidin-2-amine |
130
|
418
|
8fgcA |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 6-(5-(2-aminoethyl)-2,3-difluorophenethyl)-4-methylpyridin-2-amine |
139
|
418
|
8fg9A |
Structure of rat neuronal nitric oxide synthase heme domain in complex with 6-(5-(2-(dimethylamino)ethyl)-2,3-difluorophenethyl)pyridin-2-amine |
185
|
494
|
7um9A |
Human aldh1a1 with bound compound cm38 |
62
|
188
|
7ttvA |
E.coli dsba in complex with 4-phenyl-2-(3-phenylpropyl)thiazole-5-carboxylic acid |
122
|
406
|
7wyfA |
Plasmodium falciparum dihydroorotate dehydrogenase (dhodh) in complex with its inhibitor 50 |
49
|
157
|
7rgkA |
Dfra5 complexed with nadph and 5-(3-(7-(4-(aminomethyl)phenyl)benzo[d][1,3]dioxol-5-yl)but-1-yn-1-yl)-6-ethylpyrimidine-2,4-diamine (ucp1223) |
48
|
157
|
7rgoA |
Dfra5 complexed with nadph and 4'-chloro-3'-(4-(2,4-diamino-6-ethylpyrimidin-5-yl)but-3-yn-2-yl)-[1,1'-biphenyl]-4-carboxamide (ucp1228) |
47
|
156
|
7rgjA |
Dfra1 complexed with nadph and 5-(3-(7-(4-(aminomethyl)phenyl)benzo[d][1,3]dioxol-5-yl)but-1-yn-1-yl)-6-ethylpyrimidine-2,4-diamine (ucp1223) |
65
|
188
|
7s1lA |
Crystal structure of e.coli dsba in complex with compound mips-0001896 (compound 72) |
64
|
188
|
7s1cA |
Crystal structure of e.coli dsba in complex with compound mips-0001897 (compound 1) |
65
|
188
|
7s1fA |
Crystal structure of e.coli dsba in complex with compound mips-0001886 (compound 38) |
66
|
188
|
7s1dA |
Crystal structure of e.coli dsba in complex with compound mips-0001877 (compound 39) |
48
|
164
|
7tj3A |
Crystal structure of a dihydrofolate reductase fola from stenotrophomonas maltophilia bound to nadp and p218 |
168
|
473
|
7sv2A |
Human cytochrome p450 (cyp) 3a5 ternary complex with azamulin |
146
|
382
|
7s87A |
Crystal structure of dihydroorotate dehydrogenase from plasmodium falciparum in complex with orotate, fmn, and inhibitor ncgc00600348-01 |
186
|
523
|
7rybA |
S. cerevisiae cyp51 y140h/i471t - double mutant complexed with voriconazole |
195
|
529
|
7ryaA |
S. cerevisiae cyp51 i471t mutant complexed with itraconazole |
193
|
527
|
7ry8A |
S. cerevisiae cyp51 y140h mutant complexed with voriconazole |
195
|
527
|
7ry9A |
S. cerevisiae cyp51 i471t mutant complexed with voriconazole |
193
|
528
|
7ryxA |
S. cerevisiae cyp51 complexed with vt-1129 |
45
|
164
|
7km8A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001914, orthorhombic crystal from |
40
|
163
|
7km9A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001913, tetragonal crystal from |
44
|
170
|
7ki9A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001912 |
42
|
163
|
7ki8A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001580 |
40
|
163
|
7km7A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001914, tetragonal crystal from |
101
|
362
|
7mtuA |
Crystal structure of the catalytic domain of the inosine monophosphate dehydrogenase from bacillus anthracis in the complex with imp and the inhibitor p221 |
155
|
470
|
7ks8A |
Crystal structure of human cyp3a4 with the caged inhibitor |
137
|
469
|
7ksaA |
Crystal structure of human cyp3a4 with the caged inhibitor |
125
|
392
|
6x5yA |
Ido1 in complex with compound 4 |
132
|
374
|
7kyvA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm634 (3-methyl-n-(1-(5-methylisoxazol-3-yl)ethyl)-4-(4-(trifluoromethyl)benzyl)-1h-pyrrole-2-carboxamide) |
147
|
378
|
7kz4A |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm705 (n-(1-(1h-1,2,4-triazol-3-yl)ethyl)-3-methyl-4-(1-(6-(trifluoromethyl)pyridin-3-yl)cyclopropyl)-1h-pyrrole-2-carboxamide) |
148
|
378
|
7l01A |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm782 (n-(1-(5-cyano-1h-pyrazol-3-yl)ethyl)-3-methyl-4-(1-(6-(trifluoromethyl)pyridin-3-yl)cyclopropyl)-1h-pyrrole-2-carboxamide) |
152
|
381
|
7kykA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm589 (ethyl 3-methyl-4-((4-(trifluoromethyl)benzo[d]oxazol-7-yl)methyl)-1h-pyrrole-2-carboxylate) |
149
|
382
|
7kyyA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm697 (3-methyl-n-(1-(5-methylisoxazol-3-yl)ethyl)-4-(6-(trifluoromethyl)-1h-indol-3-yl)-1h-pyrrole-2-carboxamide) |
153
|
393
|
7kzyA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm778 (3-methyl-n-(1-(5-methyl-1h-pyrazol-3-yl)ethyl)-4-(1-(6-(trifluoromethyl)pyridin-3-yl)cyclopropyl)-1h-pyrrole-2-carboxamide) |
147
|
381
|
7l0kA |
Crystal structure of plasmodium falciparum dihydroorotate dehydrogenase bound with inhibitor dsm784 (3-(1-(3-methyl-4-((6-(trifluoromethyl)pyridin-3-yl)methyl)-1h-pyrrole-2-carboxamido)ethyl)-1h-pyrazole-5-carboxamide) |
40
|
159
|
7k6cA |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium abscessus atcc 19977 / dsm 44196 with nadp and inhibitor p218 |
43
|
163
|
7k68A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001565 |
45
|
165
|
7k62A |
Crystal structure of dihydrofolate reductase from mycobacterium kansasii in complex with nadp and inhibitor p218 |
45
|
163
|
7k69A |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001574 |
45
|
163
|
7k6aA |
Crystal structure of dihydrofolate reductase (dhfr) from mycobacterium ulcerans agy99 in complex with nadp and inhibitor sddc-0001575 |
143
|
365
|
6vndA |
Quaternary complex of human dihydroorotate dehydrogenase (dhodh) with flavin mononucleotide (fmn), orotic acid and ag-636 |
126
|
469
|
7kvjA |
Human cyp3a4 bound to an inhibitor |